PNC Financial Services Group
VOR icon

PNC Financial Services Group’s Vor Biopharma VOR Stock Holding History

PNC Financial Services Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.39K Buy
+246
New +$3.47K ﹤0.01% 4323
2021
Q4 		– Sell
-100
Closed -$31K – 4628
2021
Q3 		$31K Buy
100
+50
+100% +$14.9K ﹤0.01% 3332
2021
Q2 		$19K Buy
+50
New +$24.7K ﹤0.01% 3502

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group's VOR Position: Q1 2026 in Review

PNC Financial Services Group opened a new position in Vor Biopharma (VOR) in Q1 2026: 246 shares worth $4.39K. The stake represents ﹤0.01% of the portfolio and ranks #4323 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in VOR as recently as Q3 2021.

PNC Financial Services Group first reported a position in VOR in Q2 2021 and has held it in 3 quarters since. The position peaked at $31K in Q3 2021. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • PNC Financial Services Group held 246 shares of Vor Biopharma worth $4.39K as of Q1 2026.
  • Vor Biopharma was a new PNC Financial Services Group position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4323 holding.
  • PNC Financial Services Group first reported a position in Vor Biopharma in Q2 2021 and has held it in 3 quarters since.
  • PNC Financial Services Group's Vor Biopharma position peaked at $31K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.